Anti-Dopamine Receptor D1 (DRD1), Titer

Other names: Anti-Dopamine Receptor D1

Optimal result: 500 – 2000 titer

A high Anti-Dopamine Receptor D1 (DRD1) titer suggests the immune system is producing antibodies that may be interacting with or interfering with D1 dopamine receptors. Elevated levels may be associated with immune-mediated neuropsychiatric symptoms such as sudden-onset OCD, tics, anxiety, behavioral changes, mood swings, or movement abnormalities. High titers can indicate an active or recent immune trigger, often following infections such as strep, mycoplasma, or other immune stressors.
Interpretation is most meaningful when considered together with other neuronal antibody titers and CaM Kinase II activation.

A low or normal DRD1 titer indicates no significant autoantibody activity against the D1 dopamine receptor. This means there is no clear evidence of immune targeting of this receptor at the time of testing. Low titers do not rule out neuro-immune symptoms from other pathways, which is why the full panel—including DRD2L, anti-tubulin, anti-lysoganglioside GM1, and CaMKII—is often reviewed together.

Anti-Dopamine Receptor D1 (DRD1) antibodies are immune proteins that mistakenly target the D1 dopamine receptor, a receptor involved in movement, mood, motivation, and behavior regulation. Elevated titers may indicate an immune response affecting neuronal tissue, as seen in conditions such as PANS, PANDAS, and other neuro-immune disorders. This test helps identify whether the immune system is interacting abnormally with D1 receptors in the brain.

The Anti-Dopamine Receptor D1 (DRD1) test measures autoantibodies directed against the D1 dopamine receptor, an important signaling receptor found in regions of the brain responsible for behavior, mood, movement control, executive function, and emotional regulation. The presence of these antibodies may indicate that the immune system is mistakenly targeting neuronal structures—a process known as autoimmune or immune-mediated neuroinflammation.

D1 receptors play a key role in dopamine signaling, affecting reward pathways, memory, decision-making, motor coordination, and impulse control. When antibodies bind to these receptors, they may alter dopamine activity and contribute to sudden or severe neuropsychiatric symptoms. Elevated DRD1 titers have been reported in children and adolescents experiencing symptoms associated with PANS (Pediatric Acute-Onset Neuropsychiatric Syndrome), PANDAS, Sydenham chorea, and other immune-triggered neurological conditions.

This marker is part of the Autoimmune Brain Panel™, which evaluates autoantibodies thought to influence neuronal pathways. While the presence of DRD1 antibodies is not diagnostic on its own, it provides valuable supporting evidence when combined with clinical symptoms and other immune markers such as anti-DNase B, ASO, and other neuronal autoantibodies (DRD2L, anti-tubulin, anti-lysoganglioside GM1).

Results should be interpreted alongside the full panel and a clinician’s assessment, as titers can vary and must be understood in clinical context.

Anti-Dopamine Receptor D1 (DRD1), Titer
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond Anti-Dopamine Receptor D1 (DRD1), Titer — 10,000+ markers explained
One Anti-Dopamine Receptor D1 (DRD1), Titer result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro